OUTPACE

Serial Number 99007063
641

Registration Progress

Application Filed
Jan 17, 2025
Under Examination
Approved for Publication
Published for Opposition
Registered

Attorney Assistance

Non-Final Action Mailed
Due: Oct 03, 2025 70 days

Trademark Image

OUTPACE

Basic Information

Serial Number
99007063
Filing Date
January 17, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
641
Status Date
Jul 3, 2025
Application
Pending
Classes
042

Rights Holder

Outpace Bio, Inc.

03
Address
700 Dexter Ave N, Ste 300
Seattle, WA 98109

Ownership History

Outpace Bio, Inc.

Original Applicant
03
Seattle, WA

Legal Representation

Attorney
Sydney R. Jensen

USPTO Deadlines

Next Deadline
70 days remaining
Non-Final Action Mailed
Due Date
October 03, 2025
Extension Available
Until January 03, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

6 events
Date Code Type Description Documents
Jul 3, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jul 3, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 3, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 27, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 17, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 17, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Drug discovery and development; product research and development; scientific research and development services; pharmaceutical research and development; development of pharmaceutical preparations and drugs; identification, production and development of therapeutics, cell therapies, bioengineered cells and proteins for the treatment and prevention of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders; identification, production and development of cell therapy solutions, namely protein design and custom cell programming; scientific, medical, biotechnology, biomedical, and pharmaceutical research, development, testing and analysis services; protein engineering and design services; cell programming services; research, development, discovery and consulting services in the fields of cell therapy and immuno-oncology; research, development, engineering and testing services in the fields of therapeutics, cell therapies, biologics, medicine, and pharmaceuticals; medical and clinical research and development services; scientific research and development, scientific laboratory services, medical and scientific research, biotechnology research and synthetic biology research, all of the foregoing relating to human beings; development of pharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders; development of pharmaceutical preparations and drugs in the field of immunotherapy; development of pharmaceutical preparations and drugs in the field of cell therapy; development of pharmaceutical preparations and drugs in the field of gene therapy; medical research laboratory services, namely, tissue material processing and analysis in the field of cell therapy and immuno-oncology; biotechnology laboratory services; scientific and medical laboratory services; genetic engineering services; engineering of biological cells, cellular targets, proteins, and antibodies for others; providing a website featuring information in the scientific, medical, biotechnology, biomedical, and pharmaceutical fields; provision of drug discovery, development and testing information; providing a website featuring information in the field of drug discovery, development and testing; provision of information in the field of prevention and treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders; providing a website featuring information in the field of prevention and treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders; provision of information in the field of cell therapy and immuno-oncology; providing a website featuring information in the field of cell therapy and immuno-oncology; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing a website featuring information in the field of pharmaceuticals and clinical trials; provision of scientific, medical, biotechnology, biomedical, and pharmaceutical information; providing information relating to the diagnostic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of human diseases, disorders and conditions;

Classification

International Classes
042